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Abstracts / Urological Science 27 (2016) S36eS52S46Results: Total 48 patients with D'Amico intermediate- and high-risk CaP
were analyzed. The mean patient age, BMI, preoperative PSA, and Gleason
score at biopsy appears equivalent but there're signiﬁcant statistic higher
percentage of cT2c in control group and a trend of higher percentage of
cT3b in NHT group. Shorter operative time (153.5 minutes v.s. 113.3 mi-
nutes, p¼0.0002) and lesser amount of blood loss (147.08ml v.s. 93.75ml,
p¼0.131) were found in NHT group. The average period of biochemical
recurrence (BCR) was similar (5.33 months v.s. 6.54 months, p¼0.523) but
the overall BCR rate was signiﬁcantly lower in NHT group (87.5% v.s. 54.2%,
p¼0.026). In sub-group analysis, BCR rate was signiﬁcant lower in NHT
group if preoperative PSA level were between 10 to 20 ng/ml (66.67% v.s.
0%, p¼0.035) and >50 ng/ml (100% v.s. 55.56%, p¼0.018) while BCR rate
was 81.82% v.s. 80% (p¼0.916) in PSA 20-50 ng/ml. However, average
follow-up period was signiﬁcantly insufﬁcient in NHT group (49.46
months v.s. 20.29 months, p<0.001) although BCR usually happened in the
postoperative ﬁrst year in our study.
Conclusion: Neoadjuvant NHT followed by RaLRP seems to provide some
potential beneﬁts in shorter operative time, lesser amount of blood loss,
and lower rate of BCR during postoperative two years in patients with
intermediate- or high-risk localized CaP.
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Purpose: Although partial cystectomy is not the gold standard treatment
for muscle-invasive bladder cancer, a solitary lesion in a suitable location is
amenable to segmental resection with adequate margins. On the other
hand, when advanced gynaecological or colorectal malignancy involves
the urinary bladder, partial cystectomy has its role in bladder preservation
for better quality of life. Thus we review our experience of treating pelvic
malignancy with partial cystectomy at our institution.
Materials and Methods: From 1991 to 2010, a total of 45 patients un-
derwent partial cystectomy as en bloc resection for urological and non-
urological pelvic malignancies. Fifteen of themwere pT1-3 bladder cancer,
mostly urothelial carcinoma. The other 30 patients had urinary bladder
invasion from colorectal or gynaecological cancers. We retrospectively
reviewed these cases to evaluate the oncologic control perioperative
morbidities, and quality of life after partial cystectomy.
Results: Five of 15 patients were lost to follow up, thus the median fol-
lowupwas 48.4months (50%male, mean age: 66.2). 5-year recurrence free
rate was 50% (5/10), median time to recurrence was ten months. Mortality
rate was 20% (2/10). In mortality cases, one patient is diagnosed with bone
metastases initially and another patient is later diagnosed with pT4N2Mx
after he received radical cystectomy.16 of 29 patients were diagnosed with
bladder invasion after formal pathological report, only one case had uri-
nary bladder recurrence in 7 months. One patient expired in 3 months due
to pneumonia, 14 patients were recurrence free in urinary bladder at least
1 year, mean recurrence free time is 5.54 years.
Conclusion: From our experience, partial cystectomy for bladder cancer
control is still controversial. Further prospective or large scale study is
needed. However, en bloc resection for non-urological pelvic malignancy
in bladder invasion is feasible for tumor control.
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prostate-speciﬁc antigen (PSA) levels over than 50 ng/ml who were treated
with laparoscopic radical prostatectomywith intended wide resection.
Materials and Methods: Total twelve patients from Jan. 2007 to Dec. 2015
with prostate cancer who underwent laparoscopic radical prostatectomy
with intended wide resection had an initial PSA level over than 50 ng/ml
were included in this study. Overall survival, cancer-speciﬁc survival and,
peri-operative and post-operative parameters and pathologic features, per-
centage of neoadjuvant hormone therapy, adjuvant therapy were analyzed.
Results: ThemeanserumPSA levelwas89.4 (50.6-191.0)ng/ml. Fourpatients
(33%) received neoadjuvant hormone therapy. Two patients were classiﬁed
as stage pT2, three as pT3a, four as pT3b and three as pT4. Three patients had
pelvis lymph nodemetastasis. Six patients (50%) received adjuvant hormone
therapy. Three patients had PSA failure and two received salvage radio-
therapy. Overall survival and cancer-speciﬁc survival were 100% and 100%,
respectively, during mean follow up of 3.9 years. Continence rate was 91.7%
and average recovery time was 62 (7-287) days. Potency rate was 8.3%.
Conclusion: The study showed a relatively feasible outcome for clinically
non-metastatic but locally advanced prostate cancer with PSA levels over
than 50 ng/ml treated by laparoscopic radical prostatectomy with inten-
ded wide resection.
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Purpose: Angiomyolipoma (AML) is a benign neoplasm composed of
varying admixtures of blood vessels, smooth muscle cells, and adipose
tissue. However, it often leads to spontaneous hemorrhagic, pain or he-
maturia if large size. Invasive interventions including embolization,
nephron-sparing surgery, or even nephrectomy were suggested for larger
tumor. Due to increase risk of bleeding in larger tumor during operation,
preoperation transcatheter arterial embolization (TAE) in larger tumor
maybe can make the surgery more smoothly and decrease intra-operation
blood loss. Hence, we are here to share our hospital’s clinical experience.
Materials and Methods: From March 2012 to November 2015, 13 cases of
large AML (tumor size S7cm) underwent the nephron-sparing surgery in
Chi Mei Medical Center. Preoperation transcatheter arterial embolization
wasperformed in 6 cases (TAEgroup) and theother 7 cases are not (Non-TAE
group). Patient demographics, tumor characteristics, intraoperative, and
postoperativedata including tumor size,warm ischemia time, andestimated
blood loss (EBL) were analyzed and compared between these two group.
Results: From March 2012 to September 2015, there were 5 male and 8
female patients met the inclusion criteria. The mean age was 46-year-old.
Most of them have the chief complaint of ﬂank pain (61.5%), because of
tumormass effect or rupture. The average tumor sizewas 11.7cm (7-22) and
the average nephrometry score was 8. In the TAE group, mean warm
ischemia time (WIT) was 5 min 02 sec and Non-TAE group was 11 min 32
sec. Mean blood loss was 1650ml (300-4000) in TAE group and 1900ml
(50~7200) inNon-TAE group. Themeanpost operation length of l staywas 5
days in TAE group and 6.4 days in Non-TAE group. In Non-TAE group, there
were 3 patient (43%) showed residual tumor during post op follow up im-
aging study and only 1 patient (16%) showed residual tumor in TAE group.
Conclusion: In large AML case, TAE before partial nephrectomy had
shorterWIT, decrease intra-operation blood loss, shorter length of stay and
fewer residual tumor than those did not performed TAE.
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